Latest News:  
Beijing   Sunny    27 / 13 ℃  City Forecast

Home>>Life & Culture >> Health

Cuba to test effective new AIDS vaccine on humans

(Xinhua)

13:43, March 07, 2012

HAVANA, March 6 (Xinhua) -- Cuba has unveiled a new AIDS vaccine which has successfully been tested on mice, and the country is ready to begin human testing soon, a local newspaper said on Tuesday.

The Teravac-HIV-1 vaccine designed to fight AIDS is the result of cutting edge genetic engineering techniques, and has been presented to more than 600 scientists from 38 countries attending the 24th International Biotech Congress here, Juventud Rebelde Daily said.

The vaccine will initially be tested on a very small and controlled group of AIDS patients in the primary stages of the disease,the newspaper quoted Enrique Iglesias, head of the biotech research team that designed the vaccine.

The vaccine was developed from a recombinant protein with virus-like particles which stimulate an immune response, he noted.

Iglesias said the testing of the vaccine on the patients represented a "clinical trial, so expectations should not go beyond that."

The trials are to measure the safety of the vaccine, he said, adding that "developing a possible vaccine requires many years of laboratory research" before discovering something that can be tested on humans.

About 15,400 registered AIDS patients live in Cuba currently, making it one of the countries with the lowest rate of infection worldwide.

Cuban health officials said the government invests more than 200 million U.S. dollars a year on prevention programs and medical care for AIDS patients.

Cuba markets more than 100 high-tech medical products in about 40 countries with revenues of about 200 million dollars a year.

International experts rate Cuba's biotech industry as the most advanced among developing nations.

Email|Print|Comments(Editor:王莉莉)

Leave your comment1 comments

  1. Name

HBvDYojXvxMaLxB at 2012-05-1541.158.128.*
Lauric acid was first discovered as the main artivinal and antibacterial substance in human breast milk. It is a medium chain, saturated fatty acid that is also found in coconut products. Monolaurin is the glycerol ester of lauric acid and is more biologically active than lauric acid. Monolaurin has been shown to be active against influenza virus, pneumovirus, paramyxovirus (Newcastle), morbillivirus (rubeola), coronavirus (avian infectious, bronchitis virus), herpes simplex I II, CMV, EBV, and HIV. Monolaurin disrupts the lipid bilayer of the virus preventing attachment to susceptible host cells. It binds to the lipid-protein envelope of the virus and inactivates the virus. Monolaurin inhibits the replication of viruses by interrupting the binding of virus to host cells and prevents uncoating of viruses necessary for replication and infection. Monolaurin can remove all measurable infectivity by directly disintegrating the viral envelope. Monolaurin binding to the viral envelope makes a virus more susceptible to host defenses.
  

Selections for you


  1. Chinese martial arts promoted in schools

  2. APF graduating cadets carry out comprehensive drill

  3. Second batch of traditional architectural culture travel destinations in China

  4. Mongolian culture courses taught in China's Hohhot

Most Popular

What's happening in China

Newly-built vessel to sail for South China Sea gasfield

  1. Teacher injured from saving students conscious
  2. China to increase residential land supplies
  3. Lingering drought dries rivers, reservoirs
  4. A new rule that makes parents get divorced
  5. Anti-corruption survey results questioned

PD Online Data

  1. Spring Festival
  2. Chinese ethnic odyssey
  3. Yangge in Shaanxi
  4. Gaoqiao in Northern China
  5. The drum dance in Ansai